FDA Approves Four Generic Forms of Zidovudine for U.S. Sales After Retrovir''s Patent Expires
Thu, 22 Sep 2005 08:00 PM EST
... FDA on Monday announced it has granted approval for four forms of the generic antiretroviral drug zidovudine to be sold in the U.S., after http://www.gsk.com/GlaxoSmithKline''s patent on the drug -- sold under the brand name Retrovir -- expired on Saturday, Dow Jones reports... click link for more info. ...
Related Topics
- Zidovudine Capsule
- Zidovudine Injection
- Zidovudine Oral Syrup
- Lamivudine and Zidovudine
- Patent Lean
- Patent Ductus Arteriosus
- Abacavir, Zidovudine and Lamivudine
- Drug and Medical Device Safety
- Tacrolimus ointment
- Lamivudine
- Lead
- Mammography
- Carcinogens
- Carvedilol
- Amphetamine and Dextroamphetamine ER
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Leuprolide Implant
- Pneumococcal Polyvalent Vaccine
- Amlodipine and Atorvastatin

Not Signed In -


